SUBSCRIBE
SUBSCRIBE

Aktis Oncology, Inc.

NEWS
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.
February 6, 2026
 · 
5 min read
 · 
Tristan Manalac
Pictured: Eli Lilly Campus in San Diego
Business
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology
Eli Lilly is paying $60 million upfront to Aktis Oncology to discover and develop novel tumor-targeting radiopharmaceuticals, as radiopharma dealmaking continues to heat up in 2024.
May 21, 2024
 · 
2 min read
 · 
Kate Goodwin
Business
BioSpace Movers & Shakers, Jan. 21
Biopharma and life sciences companies made numerous appointments this week to boards and executive teams. These Movers & Shakers will position the companies for future growth.
January 20, 2022
 · 
8 min read
 · 
Alex Keown
IN THE PRESS
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
AKTIS ONCOLOGY APPOINTS KYLE KUVALANKA CHIEF FINANCIAL OFFICER
November 5, 2025
 · 
3 min read
Press Releases
Aktis Oncology to Participate in Upcoming September 2025 Investor Conferences
September 10, 2025
 · 
2 min read
Press Releases
Aktis Oncology Appoints Accomplished Life Sciences Industry Veteran Mike Sherman to its Board of Directors
August 8, 2025
 · 
3 min read
Press Releases
AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-1189, ACROSS MULTIPLE TUMOR TYPES
May 28, 2025
 · 
4 min read
Press Releases
AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE
February 25, 2025
 · 
1 min read
Press Releases
Aktis Oncology Appoints Biotech Industry Veteran Mary Thistle to its Board of Directors
February 4, 2025
 · 
3 min read
Press Releases
Aktis Oncology Announces $175 Million Oversubscribed Series B Financing to Further Advance Its Proprietary Radiopharmaceutical Pipeline
October 1, 2024
 · 
3 min read
Press Releases
AKTIS ONCOLOGY TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
August 28, 2024
 · 
1 min read
Business
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER
May 30, 2024
 · 
3 min read
Load More
JOBS